Risk factors for bone fractures in type 2 diabetes and the impact of once-weekly exenatide: insights from an EXSCEL post-hoc analysis
Bone fractures in people with T2D occur more frequently in those with diabetic neuropathy, but less frequently in those taking metformin. No evidence was seen of any impact of EQW treatment on bone fractures.
Authors
- Rury R. Holman (ORCID: https://orcid.org/0000-0002-1256-874X)
- Ruth L. Coleman (ORCID: https://orcid.org/0000-0002-5194-8550)
- Ernesto Maddaloni (ORCID: https://orcid.org/0000-0003-3844-9463)
Institutions
- University of Oxford (GB)
- Oxford Centre for Diabetes, Endocrinology and Metabolism (GB)
Publication Details
- Journal
- Diabetes Research and Clinical Practice
- Published
- 2025-03-28
- DOI
- https://doi.org/10.1016/j.diabres.2025.112125
- Citations
- 8
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 6.45